Related Experiment Videos
Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study
Huanyu Long1, Dian Chen, Lanhe Chu
1Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Medicine
|July 7, 2026
Summary
This study used Mendelian randomization to identify circulating inflammatory proteins linked to chronic obstructive pulmonary disease (COPD) risk. Specific proteins like CCL28 and CD40 were associated with lower COPD risk, while Flt3L and CD6 were linked to higher risk.
Area of Science:
- Genetics
- Immunology
- Pulmonology
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue characterized by high prevalence, morbidity, and mortality.
- While recognized as a systemic inflammatory condition, the precise circulating inflammatory proteins influencing COPD development and progression are not fully understood.
Purpose of the Study:
- To investigate the association between genetically predicted circulating inflammatory protein levels and the risk of developing COPD using a Mendelian randomization approach.
Main Methods:
- Employed Mendelian randomization (MR) utilizing large-scale genome-wide association study (GWAS) data for COPD cases and controls, alongside GWAS data for circulating inflammatory proteins.
- Applied the inverse-variance weighted method as the primary analysis, with complementary methods (Wald ratio, Weighted Median, MR-Egger, etc.) for robustness.
- Conducted comprehensive sensitivity analyses (Cochran's Q, MR-Egger intercept, MR-PRESSO, leave-one-out) to assess heterogeneity and pleiotropy, including cis-acting protein quantitative trait locus-restricted analyses.
Main Results:
- Higher genetically predicted levels of CCL28, CD40, and urokinase-type plasminogen activator were associated with a reduced risk of COPD.
- Conversely, elevated levels of Flt3L and CD6 were linked to an increased risk of COPD.
- Sensitivity analyses confirmed the robustness of findings, showing no significant heterogeneity or directional pleiotropy.
Conclusions:
- Circulating inflammatory proteins, specifically CCL28, CD40, urokinase-type plasminogen activator, Flt3L, and CD6, are implicated in the pathogenesis of COPD.
- These findings provide potential novel targets for understanding and managing COPD.
- Further research is warranted to validate these associations and elucidate the underlying biological mechanisms.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.